SOD3 and colorectal cancer: The present review focuses on SOD3 since two recent reports have shown that the cancer-driven repression of this anti-oxidant enzyme is related to tumor vessel abnormalization and T-cell exclusion in both experimental and primary colorectal cancers (13, 14).